RxDoctor Payments Data

Julia Loeb, MD

Family Medicine · Beachwood, OHNPI 1326301003

Payments from drug & device makers

$1,191in general payments, 2019–2025

Across 67 payments — averaging $17.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$355
  • Pfizer$232
  • GSK$126
  • Novo Nordisk$89
  • Astellas Pharma US Inc$75
  • Abbott$58
  • plus $255 from 10 others

What the payments were for

  • Food & beverage$1,11694%
  • Education$756%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,191 in reported general payments places this provider in the 65th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$47,802
Medicare patients
184
Services billed
681

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban84$84,828
MounjaroTirzepatide74$81,540
JardianceEmpagliflozin71$76,925
OzempicSemaglutide34$32,979
FarxigaDapagliflozin Propanediol23$30,710
TrulicityDulaglutide18$23,125
Trijardy XrEmpaglifloz/Linaglip/Metformin20$12,557
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$8,667
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$5,064
Atorvastatin Calcium408$3,452
JanuviaSitagliptin Phosphate11$3,064
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$2,049
Duloxetine Hcl52$1,751
Losartan Potassium143$1,452
PaxlovidNirmatrelvir/Ritonavir16$1,429

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$16$104,66592 claims
PfizerEliquis, Paxlovid$232$86,257100 claims
Novo NordiskOzempic$89$32,97934 claims
AstraZenecaFarxiga$30$30,71023 claims
GSKAnoro Ellipta$126$8,66716 claims
MerckJanuvia$21$3,06411 claims
AbbVieSynthroid$355$80727 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Beachwood

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →